Am J Perinatol 2011; 28(8): 643-650
DOI: 10.1055/s-0031-1276739
© Thieme Medical Publishers

Effect of Maternal Age on the Risk of Stillbirth: A Population-Based Cohort Study on 37 Million Births in the United States

Jacques Balayla1 , 3 , Laurent Azoulay2 , 3 , Jonathan Assayag2 , 3 , Alice Benjamin3 , 4 , Haim A. Abenhaim1 , 3
  • 1Department of Obstetrics and Gynecology, Jewish General Hospital, Montreal, Quebec, Canada
  • 2Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
  • 3McGill University, Montreal, Quebec, Canada
  • 4Royal Victoria Hospital, Montreal, Quebec, Canada
Further Information

Publication History

Publication Date:
03 May 2011 (online)

Preview

ABSTRACT

The objective of our study was to evaluate the incidence and effect of maternal age on the risk of stillbirth. We conducted a population-based cohort study using the Centers for Disease Control and Prevention's “Linked Birth-Infant Death” and “Fetal Death” data files. We excluded all births of gestational age under 24 weeks and those with reported congenital malformations. We estimated the adjusted effect of maternal age on the risk of stillbirth using logistic regression analysis. There were 37,504,230 births that met study criteria, of which 130,353 (3.5/1,000) were stillbirths. Rates of stillbirth remained constant throughout the 10 years. As compared with women between the ages of 25 and 30, decreasing maternal age was associated with the following risk of stillbirth: odds ratio (OR) 0.95 (95% confidence interval [CI] 0.93 to 0.97) for ages 20 to 25; OR 0.97 (95% CI 0.94 to 0.99) for ages 15 to 20; and OR 1.32 (95% CI 1.18 to 1.47) for ages <15. Increasing maternal age was associated with an increasing risk of stillbirth: OR 1.02 (95% CI 0.99 to 1.04) for ages 30 to 35, OR 1.25 (95% CI 1.21 to 1.28) for ages 35 to 40, OR 1.60 (95% CI 1.53 to 1.67) for ages 40 to 45, and OR 2.22 (95% CI 1.91 to 2.53) for ages >45. Although the overall risk is low, the risk of stillbirth increases considerably in women at the extremes of the reproductive age spectrum. Antenatal surveillance may be justified in these women.

REFERENCES

Haim A AbenhaimM.D. M.P.H. 

Pavillion H, Room 325, Department of Obstetrics and Gynecology, Jewish General Hospital, McGill University

5790 Cote-Des-Neiges, Montréal, QC, Canada H3S 1Y9

Email: haim.abenhaim@gmail.com